Hytrin

High Blood Pressure

Hytrin is used to treat hypertension (high blood pressure). It may be prescribed alone or in combination with other blood pressure medications. Lowering high blood pressure helps prevent serious health complications, such as:

• Heart attacks
• Strokes
• Kidney problems

Enlarged Prostate (BPH)

This medication is also used to treat the symptoms of benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland in men. It works by relaxing the muscles in the prostate and the neck of the bladder, which helps improve urine flow. Common symptoms it addresses include:

• A weak or interrupted urine stream
• Difficulty starting urination
• Frequent or urgent need to urinate
• Waking up often at night to urinate

While Hytrin helps relieve these symptoms by improving flow, it does not shrink the actual size of the prostate gland.

Relaxing Blood Vessels

Hytrin belongs to a class of medications called alpha-1-adrenergic blockers. For the treatment of high blood pressure, it works by blocking specific nerve impulses that cause blood vessels to tighten. By relaxing the smooth muscles in the walls of the veins and arteries, the medication allows blood to pass through more easily, which reduces overall blood pressure.

Improving Urinary Symptoms

In men with benign prostatic hyperplasia (BPH), or an enlarged prostate, Hytrin helps relieve urinary symptoms by relaxing the smooth muscles located in the bladder neck and the prostate gland. This relaxation reduces the pressure on the urethra, making it easier to urinate and improving the strength of the urine stream.

It is important to note that while Hytrin helps manage the symptoms of an enlarged prostate by relaxing muscle tone, it does not physically shrink the size of the prostate gland itself.

Common Side Effects

Many people using this medication do not have serious side effects. Common symptoms may include:

• Dizziness or lightheadedness, especially when standing up
• Drowsiness or tiredness
• Headache
• Nausea
• Stuffy or runny nose
• Swelling of the hands, feet, ankles, or lower legs
• Blurred vision
• Decreased sexual ability

Serious Side Effects

Contact your doctor immediately or seek emergency medical care if you experience any of the following:

• Fainting or severe dizziness
• Fast, pounding, or irregular heartbeat
• Chest pain
• Shortness of breath
• A painful erection or an erection that lasts for 4 hours or longer
• Sudden vision changes

Blood Pressure and Fainting

Hytrin may cause a significant drop in blood pressure, which can lead to fainting (syncope). This effect is most common after the very first dose, when the dose is increased, or if treatment is restarted after a break. To reduce this risk, the initial dose is usually low and taken at bedtime.

Symptoms of low blood pressure include:

• Dizziness or lightheadedness
• Feeling faint
• Palpitations

Eye Surgery Risks

People planning to have cataract or glaucoma surgery should inform their eye surgeon if they are taking or have previously taken Hytrin. A condition called Intraoperative Floppy Iris Syndrome (IFIS) can occur during these procedures in patients using alpha-blockers. Surgeons may need to adjust their technique to prevent complications.

Priapism

In rare cases, alpha-blockers like Hytrin can cause priapism, which is a painful erection lasting several hours that is not related to sexual activity. This is a medical emergency that requires immediate treatment to prevent permanent tissue damage.

Prostate Cancer Screening

Because the symptoms of benign prostatic hyperplasia (BPH) and prostate cancer can be similar, healthcare providers typically rule out prostate cancer before starting Hytrin treatment for BPH.

Precautions and Interactions

Caution is advised when using Hytrin alongside other medications that lower blood pressure, including phosphodiesterase-5 (PDE5) inhibitors used for erectile dysfunction. Combining these drugs can increase the risk of symptomatic low blood pressure.

Pregnancy

There are no adequate and well-controlled studies regarding the use of Hytrin in pregnant women. While animal studies have not demonstrated fetal harm at high doses, animal data is not always indicative of human response. This medication should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

It is currently unknown whether Hytrin passes into human breast milk. Because many medications are excreted in milk, caution is advised when using this drug while nursing. Individuals who are breastfeeding or planning to breastfeed should consult with their healthcare provider to evaluate the risks and benefits of treatment.

Available Forms

Hytrin is supplied as a capsule for oral administration. While the active ingredient, terazosin, may be available in other forms as a generic medication, the brand-name Hytrin is specifically produced as a capsule.

FDA Approval Status

Hytrin, the brand name for the active ingredient terazosin hydrochloride, is approved by the U.S. Food and Drug Administration (FDA) for the following indications:

• Hypertension: For the treatment of high blood pressure, used either alone or in combination with other antihypertensive drugs.
• Benign Prostatic Hyperplasia (BPH): For the treatment of the signs and symptoms of an enlarged prostate.

Boxed Warnings and REMS

There are currently no FDA boxed warnings for Hytrin. A boxed warning is the FDA’s most serious warning for certain significant risks. Additionally, there is no Risk Evaluation and Mitigation Strategy (REMS) required for this medication.

Regulatory Classification

Hytrin is not a controlled substance. It is available only by prescription from a licensed healthcare provider. While the brand name Hytrin has been discontinued in some markets, generic versions (terazosin) remain FDA-approved and available.

Restarting Treatment

If treatment with Hytrin is interrupted for several days or more, it should not be restarted at the previous maintenance dose. Instead, therapy must be restarted at the initial low dose, usually 1 mg at bedtime, and then gradually increased under medical supervision. This is necessary to avoid a sudden and severe drop in blood pressure.

Potential Effects of Discontinuation

Stopping Hytrin may lead to the return of the conditions it was prescribed to manage. For individuals with high blood pressure, readings may increase once the medication is out of the system. For those with an enlarged prostate, urinary symptoms such as frequent urination or a weak stream may worsen.

The most significant risk occurs when restarting the drug after a break. This can cause a 'first-dose effect,' characterized by extreme dizziness or fainting (syncope). To reduce this risk, healthcare providers typically advise taking the first dose of a restarted regimen before sleep and avoiding activities that require alertness until the body adjusts.